Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Arena Pharmaceuticals, Inc.
(NQ:
ARNA
)
7.990
USD
+0.030 (+0.38%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Arena Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Arena Pharmaceuticals' Lorcaserin to be Featured in Presentations at 18th European Congress on Obesity
May 20, 2011
from
PR Newswire
Stocks Earnings Updates Are: ARNA, DIS, DPTR, GMR, HRBN Reports InvestorCentral.us
May 11, 2011
from
EmailWire.Com Press Releases
Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
May 10, 2011
from
PR Newswire
Down but Not out -- Obesity Drugs Continue Journey Towards Approval
May 06, 2011
The Bedford Report Provides Analyst Research on Arena Pharmaceuticals & Orexigen Therapeutics
Read More
from
Marketwired News Releases
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
May 06, 2011
from
PR Newswire
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
May 04, 2011
from
PR Newswire
Arena Pharmaceuticals Announces $35.5 Million Financing
March 29, 2011
- Arena to Use Approximately $17.7 Million of Proceeds to Prepay Outstanding Debt -
Read More
from
PR Newswire
Healthcare Acquisition Activity on the Rise as Key Patents Run Out
March 24, 2011
The Bedford Report Provides Analyst Research on Amylin & Arena Pharmaceuticals
Read More
from
Marketwired News Releases
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
March 11, 2011
from
PR Newswire
Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
March 10, 2011
from
PR Newswire
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
March 08, 2011
from
PR Newswire
Arena & Exelixis Face Difficult Approval Processes
February 24, 2011
The Bedford Report Provides Analyst Research on Arena Pharmaceuticals & Exelixis
Read More
from
Marketwired News Releases
Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
February 10, 2011
from
PR Newswire
Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
February 09, 2011
from
PR Newswire
Orexigen Therapeutics Inc. is Today's Focus Stock on MicroStockProfit.com
February 01, 2011
from
GlobeNewswire News Releases
Arena Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com
January 31, 2011
from
GlobeNewswire News Releases
Arena Pharmaceuticals Announces Workforce Reduction and Provides Lorcaserin Regulatory Update
January 27, 2011
from
PR Newswire
Weighing in on the Obesity Drug Market
January 24, 2011
The Bedford Report Provides Analyst Research on Arena Pharmaceuticals & Orexigen Therapeutics
Read More
from
Marketwired News Releases
Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
January 06, 2011
from
PR Newswire
Energystockpick.com Reports on a Strong Alternative Energy Pick - Here Enterprises (HRTE)
January 06, 2011
from
EmailWire.Com Press Releases
Energystockpick.com Reports Here Enterprises Confirms Commitment to Texas
January 06, 2011
from
EmailWire.Com Press Releases
Stockpick.pro Reports Here Enterprises (HRTE) releases Further Information on Texas Wind Power
January 06, 2011
from
EmailWire.Com Press Releases
Micro Caps Top Gainers 1/4 (XOMA, SHZ, ARNA, XING) by EquityMarketReport.com
January 04, 2011
from
EmailWire.Com Press Releases
Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
December 22, 2010
-- Meeting Provides Additional Clarity on Next Steps Toward Approval --
Read More
from
PR Newswire
Most Actively Traded on NASDAQ (SIRI, ARNA, HBAN, MU) by EquityMarketReport.com
December 22, 2010
from
EmailWire.Com Press Releases
Bullish Stocks for the Holidays (ARNA, IDCC, AXP, C)
December 22, 2010
from
EmailWire.Com Press Releases
The New Pennystockfever.com Pick is... Keryx Biopharmaceuticals Inc. (KERX)
December 22, 2010
from
EmailWire.Com Press Releases
Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
December 21, 2010
from
PR Newswire
Top Percentage Losers on NASDAQ 12/21/10 (ARNA, KNDI, PPHM, ICOP) by EquityMarketReport.com
December 21, 2010
from
EmailWire.Com Press Releases
Popular Micro Cap Stocks in Focus (YRCW, ARNA, AEZS, CRBC) by EquityMarketReport.com
December 17, 2010
from
EmailWire.Com Press Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.